Units of Baxter’s Heparin Recalled
Baxter has been recalling its pre-filled Heparin units and vials since January 17. The Food and Drug Administration announced the urgent nationwide recall to consumers. The recall includes nine lots of heparin sodium injection 1000 units/mL 10mL and 30mL multi-dose vials. The recall is in response to an increase in the number of reports of adverse patient reactions that may be associated with the product. The allergic-type reactions include stomach pain or discomfort, nausea, vomiting, diarrhea, decreased or low blood pressure, chest pain, fast heart rate, dizziness, fainting, unresponsiveness, burning sensation, redness or paleness of skin, abnormal sensation of the skin, mouth or lips, flushing, increased sweating, decreased skin sensitivity, headache, general feeling of illness, restlessness, watery eyes, throat swelling, thirst and difficulty opening the mouth. Some of these reaction may be severe and even life threatening. Heparin is a prescription blood thinner. The recalled units are primarily used for hemodialysis and cardiac invasive procedures. Customers have been told to discontinue use and to separate the product from their inventory.
